| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.06. | CH BIOTECH SER (08037): SUPPLEMENTAL ANNOUNCEMENT - MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC ... | 1 | HKEx | ||
| 22.05. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS | 1 | HKEx | ||
| 22.05. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | 1 | HKEx | ||
| 22.05. | CH BIOTECH SER (08037): FORM OF PROXY | 3 | HKEx | ||
| 22.05. | CH BIOTECH SER (08037): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 22.05. | CH BIOTECH SER (08037): (1) PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; ... | 2 | HKEx | ||
| 18.05. | CH BIOTECH SER (08037): MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND ... | - | HKEx | ||
| CHINA BIOTECH SERVICES Aktie jetzt für 0€ handeln | |||||
| 15.05. | CH BIOTECH SER (08037): UPDATE ON EXEMPTED CONNECTED TRANSACTION IN RELATION TO THE ADOPTION OF SHARE AWARD SCHEME BY AND SUBSCRIPTION OF SHARES IN A ... | - | HKEx | ||
| 04.05. | CH BIOTECH SER (08037): COMPANY INFORMATION SHEET | 1 | HKEx | ||
| 04.05. | CH BIOTECH SER (08037): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 1 | HKEx | ||
| 30.04. | CH BIOTECH SER (08037): RESIGNATION OF EXECUTIVE DIRECTOR | - | HKEx | ||
| 29.04. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 29.04. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
| 29.04. | CH BIOTECH SER (08037): ANNUAL REPORT 2025 | - | HKEx | ||
| 30.03. | CH BIOTECH SER (08037): GRANT OF SHARE AWARDS | - | HKEx | ||
| 27.03. | CH BIOTECH SER (08037): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025 | - | HKEx | ||
| 06.03. | CH BIOTECH SER (08037): NOTICE OF BOARD MEETING | - | HKEx | ||
| 06.03. | CH BIOTECH SER (08037): PROFIT WARNING - REDUCTION IN LOSS | - | HKEx | ||
| 23.02. | CH BIOTECH SER (08037): (1) COMPLETION OF ISSUE OF CONVERTIBLE BONDS UNDER SPECIFIC MANDATE; AND (2) ADJUSTMENT RELATING TO THE OUTSTANDING 2024 CONVERTIBLE ... | 1 | HKEx | ||
| 05.02. | CH BIOTECH SER (08037): POLL RESULTS OF THE SPECIAL GENERAL MEETING HELD ON 5 FEBRUARY 2026 | - | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 66,80 | +0,30 % | mylife Diabetes Care, CamDiab und Dexcom geben Integration des Dexcom G7 in myLoop bekannt / Mehr Auswahl und adaptive Versorgung bei automatisierter Insulinabgabe für Menschen mit Typ-1-Diabetes | Mainz, Horw, Brunn am Gebirge (ots) - mylife Diabetes Care, CamDiab und Dexcom geben die Integration des Dexcom G7 CGM-Systems zur kontinuierlichen Glukosemessung in das automatisierte Insulinabgabesystem... ► Artikel lesen | |
| MCKESSON | 664,60 | -0,09 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,046 | -5,21 % | Mountain Valley MD Holdings Inc: Mountain Valley MD appoints advisers, grants options | ||
| BRIGHTSPRING HEALTH SERVICES | 59,22 | 0,00 % | Goldman Sachs initiates BrightSpring Health stock at Buy with $71 target | ||
| PROGYNY | 25,920 | 0,00 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| PRIVIA HEALTH GROUP | 21,410 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,350 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 15,345 | -0,03 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| BILLIONTOONE | 94,32 | -0,12 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 9,340 | 0,00 % | Anteris Technologies Global Corp.: Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance | MINNEAPOLIS and BRISBANE, Australia, June 08, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR) announced today that it has received full... ► Artikel lesen | |
| ADAPTHEALTH | 9,650 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
| GENEDX | 51,76 | -0,08 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| SIEMENS HEALTHINEERS | 34,550 | +0,52 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 5,070 | 0,00 % | Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday | ||
| FRESENIUS MEDICAL CARE | 38,050 | +0,24 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen |